• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹引起的限制性心肌病。

Restrictive cardiomyopathy caused by chloroquine.

作者信息

Iglesias Cubero G, Rodriguez Reguero J J, Rojo Ortega J M

机构信息

Department of Cardiology, Hospital Central de Asturias, University of Oviedo, Spain.

出版信息

Br Heart J. 1993 May;69(5):451-2. doi: 10.1136/hrt.69.5.451.

DOI:10.1136/hrt.69.5.451
PMID:8518071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1025112/
Abstract

A 59 year old white woman who had been treated with chloroquine phosphate for 25 years presented with signs of congestive heart failure and was diagnosed as having restrictive cardiomyopathy by non-invasive methods. Electron microscopy of a biopsy specimen of skeletal muscle showed lesions compatible with chloroquine myopathy. The patient died five weeks after presentation. Electron microscopy of heart tissue showed similar lesions to those of the skeletal muscle.

摘要

一名59岁的白人女性,使用磷酸氯喹治疗25年,出现充血性心力衰竭症状,通过非侵入性方法被诊断为限制性心肌病。骨骼肌活检标本的电子显微镜检查显示有与氯喹肌病相符的病变。患者在出现症状五周后死亡。心脏组织的电子显微镜检查显示出与骨骼肌相似的病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4f/1025112/61713e7a966c/brheartj00015-0084-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4f/1025112/7d6035141513/brheartj00015-0083-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4f/1025112/61713e7a966c/brheartj00015-0084-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4f/1025112/7d6035141513/brheartj00015-0083-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4f/1025112/61713e7a966c/brheartj00015-0084-a.jpg

相似文献

1
Restrictive cardiomyopathy caused by chloroquine.氯喹引起的限制性心肌病。
Br Heart J. 1993 May;69(5):451-2. doi: 10.1136/hrt.69.5.451.
2
Chloroquine-induced cardiomyopathy-echocardiographic features.氯喹诱发的心肌病——超声心动图特征
J Am Soc Echocardiogr. 2005 Apr;18(4):383-7. doi: 10.1016/j.echo.2004.09.029.
3
Heart transplantation in a patient with chloroquine-induced cardiomyopathy.氯喹诱导的心肌病患者的心脏移植
J Heart Lung Transplant. 2004 Feb;23(2):252-5. doi: 10.1016/S1053-2498(03)00108-6.
4
Images in cardiology. Chloroquine-induced transition from dilated to restrictive cardiomyopathy.心脏病学影像。氯喹诱导的扩张型心肌病向限制型心肌病的转变。
J Am Coll Cardiol. 2011 Jan 25;57(4):515. doi: 10.1016/j.jacc.2010.03.109.
5
[Reversible restrictive cardiomyopathy secondary to chloroquine].[氯喹所致可逆性限制型心肌病]
Med Clin (Barc). 2007 Jun 23;129(4):157. doi: 10.1157/13107491.
6
Restrictive cardiomyopathy secondary to hydroxychloroquine therapy.继发于羟氯喹治疗的限制性心肌病。
J Rheumatol. 2009 Feb;36(2):440-1. doi: 10.3899/jrheum.080305.
7
Cardiac toxicity secondary to long term treatment with chloroquine.长期使用氯喹治疗引发的心脏毒性。
Ann Rheum Dis. 2001 Mar;60(3):301. doi: 10.1136/ard.60.3.301.
8
Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits.在患有结蛋白免疫反应性物质沉积的患者中出现限制性心肌病、房室传导阻滞和轻度至亚临床型肌病。
J Am Coll Cardiol. 1998 Mar 1;31(3):645-53. doi: 10.1016/s0735-1097(98)00026-6.
9
Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles.
Jpn Circ J. 1993 Sep;57(9):928-33. doi: 10.1253/jcj.57.928.
10
Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure.
J Am Coll Cardiol. 1987 Sep;10(3):608-18. doi: 10.1016/s0735-1097(87)80204-8.

引用本文的文献

1
Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice.羟氯喹减轻 D94A 转基因小鼠扩张型心肌病表型。
Int J Mol Sci. 2022 Dec 9;23(24):15589. doi: 10.3390/ijms232415589.
2
GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition.GNS561 通过抑制自噬对 SARS-CoV-2 表现出强大的抗病毒活性。
Viruses. 2022 Jan 12;14(1):132. doi: 10.3390/v14010132.
3
A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus.系统性红斑狼疮患者心力衰竭一例。

本文引用的文献

1
ELECTROCARDIOGRAM AFTER CHLOROQUINE AND EMETINE.氯喹和吐根碱治疗后的心电图
Circulation. 1965 Aug;32:281-9. doi: 10.1161/01.cir.32.2.281.
2
Pharmacologic actions of 4-aminoquinoline compounds.4-氨基喹啉化合物的药理作用。
Am J Med. 1983 Jul 18;75(1A):5-10. doi: 10.1016/0002-9343(83)91264-0.
3
Chloroquine neuromyopathy associated with keratopathy and retinopathy.氯喹相关性神经病变伴角膜病变和视网膜病变。
JACC Case Rep. 2020 Mar 18;2(3):414-419. doi: 10.1016/j.jaccas.2019.12.040. eCollection 2020 Mar.
4
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021.药物重新利用治疗新冠肺炎的疗效与安全性:2021年立场声明
Front Pharmacol. 2021 Jun 14;12:659577. doi: 10.3389/fphar.2021.659577. eCollection 2021.
5
The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.氯喹和羟氯喹在抗击新型冠状病毒肺炎中的争议性治疗历程:一项综述
Med Drug Discov. 2021 Jun;10:100085. doi: 10.1016/j.medidd.2021.100085. Epub 2021 Mar 10.
6
Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro.几种经美国食品药品监督管理局批准的药物在体外能有效抑制新型冠状病毒感染。
Front Pharmacol. 2021 Feb 5;11:609592. doi: 10.3389/fphar.2020.609592. eCollection 2020.
7
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.SARS-CoV-2 和 HIV 靶向宿主细胞的出现和分子机制及潜在治疗方法。
Infect Genet Evol. 2020 Nov;85:104583. doi: 10.1016/j.meegid.2020.104583. Epub 2020 Oct 6.
8
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.在妊娠期研究用于治疗 2019 冠状病毒病的药物的胎盘转运和安全性。
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100159. doi: 10.1016/j.ajogmf.2020.100159. Epub 2020 Jun 22.
9
Natural history of COVID-19 and current knowledge on treatment therapeutic options.COVID-19 的自然史和当前治疗选择的治疗知识。
Biomed Pharmacother. 2020 Sep;129:110493. doi: 10.1016/j.biopha.2020.110493. Epub 2020 Jul 3.
10
Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?青蒿琥酯:会是新冠病毒肺炎治疗中氯喹的替代药物吗?
Chin Med. 2020 May 28;15:54. doi: 10.1186/s13020-020-00336-8. eCollection 2020.
Br Med J. 1967 Apr 22;2(5546):219-20. doi: 10.1136/bmj.2.5546.219.
4
Chloroquine neuromyotoxicity. Clinical and pathologic perspective.氯喹神经肌肉毒性。临床与病理学视角。
Am J Med. 1987 Mar;82(3):447-55. doi: 10.1016/0002-9343(87)90444-x.
5
Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.通过心内膜心肌活检诊断氯喹心肌病。
N Engl J Med. 1987 Jan 22;316(4):191-3. doi: 10.1056/NEJM198701223160405.
6
Changes in saccharide and phospholipid content associated with drug storage in cultured rabbit aorta muscle cells.培养的兔主动脉肌细胞中与药物储存相关的糖类和磷脂含量变化。
Lab Invest. 1991 Apr;64(4):574-84.
7
Cardiomyopathy after chloroquine treatment.氯喹治疗后出现的心肌病。
Acta Med Scand. 1977;202(5):429-31. doi: 10.1111/j.0954-6820.1977.tb16857.x.